Clinical Trial Update: Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing inhaled TPI-1020 with inhaled budesonide in smokers with mild reversible asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide (BUDESONIDE)
• TPI-1020 (TPI-1020)

Snippet

Sponsor: Syntara | Conditions: Asthma | Phase 2 | Status: COMPLETED